共 43 条
- [41] Primary treatment for patients (pts) with advanced NSCLC presenting with brain metastasis (BMs) at first diagnosis. Final results from a multi-institutional survey by oncologic centers participating to the ReVERTO (Rete per la Valutazione dell'Efficacia nella Ricerca dei Trattamenti Oncologici) Italian Network LUNG CANCER, 2005, 49 : S90 - S90
- [42] Re: Sarah P. Psutka, Roman Gulati, Michael AS Jewett, et al. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing- risks Analysis. Eur Urol 2022;81:576-85 EUROPEAN UROLOGY, 2022, 82 (05) : E146 - E147
- [43] Re: Sarah P. Psutka, Roman Gulati, Michael AS Jewett, et al. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. Eur Urol. 2022;81:576-85 EUROPEAN UROLOGY, 2022, 81 (06) : E149 - E149